The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Triazene compounds: Mechanism of action and related DNA repair systems
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome maintenance mechanisms for preventing cancer
Hoeijmakers, J. H. J. (2001) · Nature · doi:10.1038/35077232 · Cited by 3,939
Poly(ADP-ribose): novel functions for an old molecule
Schreiber, V., Dantzer, F., Ame, J.-C., & de Murcia, G. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1963 · Cited by 1,915
The multifaceted mismatch-repair system
Jiricny, J. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1907 · Cited by 1,370
Kunkel, T. A., & Erie, D. A. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133243 · Cited by 1,367
Temozolomide and treatment of malignant glioma
Friedman, H. S., Kerby, T., & Calvert, H. (2000) · PubMed · doi:10.25405/ncl.34644405 · Cited by 731
Kaina, B., Christmann, M., Naumann, S., & Roos, W. P. (2007) · DNA Repair · doi:10.1016/j.dnarep.2007.03.008 · Cited by 663
Repair of O6-alkylguanine by alkyltransferases
Pegg, A. E. (2000) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(00)00017-x · Cited by 576
Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856)
Newlands, E., Blackledge, G., Slack, J., Rustin, G., Smith, D., Stuart, N., Quarterman, C., Hoffman, R., Stevens, M., Brampton, M., et al. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.57 · Cited by 488
Denny, B. J., Wheelhouse, R. T., Stevens, M. F. G., Tsang, L. L. H., & Slack, J. A. (1994) · Biochemistry · doi:10.1021/bi00197a003 · Cited by 442
Mismatch repair and DNA damage signalling
Stojic, L., Brun, R., & Jiricny, J. (2004) · DNA Repair · doi:10.1016/j.dnarep.2004.06.006 · Cited by 396
Agarwala, S. S., & Kirkwood, J. M. (2000) · The Oncologist · doi:10.1634/theoncologist.5-2-144 · Cited by 330
Hermisson, M., Klumpp, A., Wick, W., Wischhusen, J., Nagel, G., Roos, W., Kaina, B., & Weller, M. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03583.x · Cited by 311
DNA damage tolerance, mismatch repair and genome instability
Karran, P., & Bignami, M. (1994) · BioEssays · doi:10.1002/bies.950161110 · Cited by 310
Involvement of the Mismatch Repair System in Temozolomide-Induced Apoptosis
D’Atri, S., Tentori, L., Lacal, P. M., Graziani, G., Pagani, E., Benincasa, E., Zambruno, G., Bonmassar, E., & Jiricny, J. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.2.334 · Cited by 282
ATM, a central controller of cellular responses to DNA damage
Khanna, K., Lavin, M., Jackson, S., & Mulhern, T. (2001) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400874 · Cited by 252
Stojic, L., Mojas, N., Cejka, P., di Pietro, M., Ferrari, S., Marra, G., & Jiricny, J. (2004) · Genes & Development · doi:10.1101/gad.294404 · Cited by 246
Baker, S. D., Wirth, M., Statkevich, P., Reidenberg, P., Alton, K. B., Sartorius, S. E., Dugan, M. H., Cutler, D. L., Batra, V. K., Grochow, L. B., et al. (1999) · PubMed · Cited by 221
O6-benzylguanine and its role in chemotherapy.
Dolan, M. E., & Pegg, A. E. (1997) · PubMed · Cited by 211
Brada, M., Judson, I., Beale, P., Moore, S., Reidenberg, P., Statkevich, P., Dugan, M., Batra, V, & Cutler, D. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690802 · Cited by 208
Tentori, L., Leonetti, C., Scarsella, M., d’Amati, G., Vergati, M., Portarena, I., Xu, W., Kalish, V. J., Zupi, G., Zhang, J., et al. (2003) · PubMed · Cited by 204
Signalling cell cycle arrest and cell death through the MMR System
O'Brien, V., & Brown, R. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi298 · Cited by 201
Amin, N. S., Nguyen, M.-N., Oh, S., & Kolodner, R. D. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.15.5142-5155.2001 · Cited by 199
Kaina, B., Ziouta, A., Ochs, K., & Coquerelle, T. (1997) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(97)00187-5 · Cited by 197
DNA bending and unbending by MutS govern mismatch recognition and specificity
Wang, H., Yang, Y., Schofield, M. J., Du, C., Fridman, Y., Lee, S. D., Larson, E. D., Drummond, J. T., Alani, E., Hsieh, P., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2433654100 · Cited by 195
Moore, M. H., Gulbis, J. M., Dodson, E. J., Demple, B., & Moody, P. C. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06410.x · Cited by 194
Chemopotentiation by PARP inhibitors in cancer therapy
Tentori, L., & Graziani, G. (2005) · Pharmacological Research · doi:10.1016/j.phrs.2005.02.010 · Cited by 192
Unmasking a killer: DNA O6-methylguanine and the cytotoxicity of methylating agents
Bignami, M., O'Driscoll, M., Aquilina, G., & Karran, P. (2000) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(00)00016-8 · Cited by 185
Degradation of the alkylated form of the DNA repair protein, O6-alkylguanine-DNA alkyltransferase
Xu-Welliver, M. (2002) · Carcinogenesis · doi:10.1093/carcin/23.5.823 · Cited by 168
Reid, J. M., Kuffel, M. J., Miller, J. K., Ríos, R., & Ames, M. M. (1999) · PubMed · Cited by 133
Current therapy for malignant melanoma.
Ss, L. (1989) · PubMed · Cited by 125
Hirose, Y., Katayama, M., Stokoe, D., Haas-Kogan, D. A., Berger, M. S., & Pieper, R. O. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.8306-8315.2003 · Cited by 122
hMutSβ Is Required for the Recognition and Uncoupling of Psoralen Interstrand Cross-Links In Vitro
Zhang, N., Lu, X., Zhang, X., Peterson, C. A., & Legerski, R. J. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.7.2388-2397.2002 · Cited by 103
Skibba, J. L., Beal, D. D., Ramírez, G., & Bryan, G. T. (1970) · PubMed · Cited by 99
Inhibition of angiogenesis by non-toxic doses of temozolomide
Kurzen, H., Schmitt, S., Näher, H., & Möhler, T. (2003) · Anti-Cancer Drugs · doi:10.1097/00001813-200308000-00003 · Cited by 97
Wild-type p53 suppresses transcription of the human O6-methylguanine-DNA methyltransferase gene.
Harris, L. C., Remack, J. S., Houghton, P. J., & Brent, T. P. (1996) · PubMed · Cited by 95
Meer, L., Janzer, R. C., Kleihues, P., & Kolar, G. F. (1986) · Biochemical Pharmacology · doi:10.1016/0006-2952(86)90419-3 · Cited by 90
Wedge, S. R., & Newlands, E. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.203 · Cited by 84
Tentori, L., Leonetti, C., Scarsella, M., d’Amati, G., Portarena, I., Zupi, G., Bonmassar, E., & Graziani, G. (2002) · Blood · doi:10.1182/blood.v99.6.2241 · Cited by 83
Rafferty, J. A., Clarke, A. R., Sellappan, D., Santibanez‐Koref, M., Frayling, I. M., & Margison, G. P. (1996) · PubMed · Cited by 82
O6-Methylguanine-DNA Methyltransferase Regulation by p53 in Astrocytic Cells
Blough, M. D., Ƶlatescu, M. C., & Cairncross, J. G. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2782 · Cited by 78
Activation of human O6-methylguanine-DNA methyltransferase gene by glucocorticoid hormone
Biswas, T., Ramana, C. V., Srinivasan, G., Boldogh, I. R., Hazra, T. K., Chen, Z., Tano, K., Thompson, E. B., & MITRA, S. P. (1999) · Oncogene · doi:10.1038/sj.onc.1202320 · Cited by 73
Role of DNA mismatch repair in apoptotic responses to therapeutic agents
Meyers, M., Hwang, A., Wagner, M. W., & Boothman, D. A. (2004) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20056 · Cited by 66
HORTON, J., & Wilson, S. H. (2006) · DNA repair · doi:10.1016/j.dnarep.2006.10.016 · Cited by 65
Sokolsky, T. D., & Alani, E. (2000) · Genetics · doi:10.1093/genetics/155.2.589 · Cited by 65
Wedge, S. R., Porteous, J. K., & Newlands, E. S. (1997) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050657 · Cited by 57
Tentori, L., Orlando, L., Lacal, P. M., Benincasa, E., Faraoni, I., Bonmassar, E., D’Atri, S., & Graziani, G. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.2.249 · Cited by 57
Kanugula, S., Goodtzova, K., Edara, S., & Pegg, A. E. (1995) · Biochemistry · doi:10.1021/bi00021a024 · Cited by 54
Tentori, L., Turriziani, M., Franco, D., Serafino, A., Levati, L., Roy, R., Bonmassar, E., & Graziani, G. (1999) · Leukemia · doi:10.1038/sj.leu.2401423 · Cited by 54
Self-citationPhase I Study of Temozolomide in Relapsed/Refractory Acute Leukemia
Seiter, K. P., Liu, D., Loughran, T. P., Siddiqui, A. D., Baskind, P., & Ahmed, T. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.01.030 · Cited by 50
Degradation of dacarbazine in aqueous solution
Shetty, B. V., Schowen, R. L., Slavik, M., & Riley, C. M. (1992) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/0731-7085(92)80096-6 · Cited by 42
Turriziani, M., Caporaso, P., Bonmassar, L., Buccisano, F., Amadori, S., Venditti, A., Cantonetti, M., D’Atri, S., & Bonmassar, E. (2006) · Pharmacological Research · doi:10.1016/j.phrs.2005.12.001 · Cited by 39
Self-citationLim, A., & Li, B. F. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00778.x · Cited by 36
Goodtzova, K., Kanugula, S., Edara, S., & Pegg, A. E. (1998) · Biochemistry · doi:10.1021/bi9811718 · Cited by 35
Dual repair modulation reverses Temozolomide resistance in vitro
Barvaux, V. A., Ranson, M., Brown, R. E., et al. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.123.3.2 · Cited by 30
Antitumour imidazotetrazines—XVI
Bull, V. L., & Tisdale, M. J. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90636-8 · Cited by 28
Beal, D. D., Skibba, J. L., Whitnable, K. K., & Bryan, G. T. (1976) · PubMed · Cited by 20
Xu‐Welliver, M., Kanugula, S., Loktionova, N. A., Crone, T. M., & Pegg, A. E. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3470527 · Cited by 17
Cited by
Benigni, R., & Bossa, C. (2011) · Chemical Reviews · doi:10.1021/cr100222q · Cited by 377
Temozolomide and Other Alkylating Agents in Glioblastoma Therapy
Strobel, H., Baisch, T., Fitzel, R., Schilberg, K., Siegelin, M. D., Karpel-Massler, G., Debatin, K.-M., & Westhoff, M.-A. (2019) · Biomedicines · doi:10.3390/biomedicines7030069 · Cited by 279
Ishibashi, M., Arai, M., Tanaka, S., Onda, K., & Hirano, T. (2012) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.35.10 · Cited by 36
Metadata
- Authors
- MARCHESI, F., TURRIZIANI, M., TORTORELLI, G., AVVISATI, G., TORINO, F., & DEVECCHIS, L.
- Venue
- Pharmacological Research
- Publisher
- Elsevier BV
- Published
- 2007-10
- Volume
- 56
- Issue
- 4
- Pages
- 275-287
- ISSN
- 1043-6618 (ISSN-L)
- OpenAlex
- W1965905617
- Cited by
- 299
- References
- 57
- FWCI
- 3.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.